Bio Pharma Dive
MARCH 28, 2025
Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal the verdict, a strategy successfully employed by Eisai.
Medical Xpress
MARCH 28, 2025
According to a recent study from the University of Jyvskyl, Finland, the impacts of everyday physical activity do not attenuate the accelerated hormonal bone loss that occurs during menopause. Effective bone-loading impacts are rare in everyday life. Future research should explore whether more targeted exercise can slow menopausal bone loss. The study suggests that impacts accumulated during everyday life are not sufficient to slow hormonal bone loss during menopause.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 28, 2025
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare bleeding disorder.
Pharmaceutical Technology
MARCH 28, 2025
The Macau Special Administrative Region (ISAF) Pharmaceutical Administration Bureau has approved IASO Bio's NDA for equecabtagene autoleucel.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
MARCH 28, 2025
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients who are eligible for treatment.
Medical Xpress
MARCH 28, 2025
In what is believed to be a world-first study, researchers from the University of Adelaide's Australian Dysautonomia and Arrhythmia Research Collaborative (ADARC) have used brain scans to identify blood flow problems in people with postural orthostatic tachycardia syndrome (POTS).
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MARCH 28, 2025
Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to oral therapy LX9851.
Bio Pharma Dive
MARCH 28, 2025
The new bid surpasses an offer SK Capital and Carlyle Group made last month for the gene therapy developer, which Bluebird’s board still supports.
Pharmaceutical Technology
MARCH 28, 2025
Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in chemotherapy.
Medical Xpress
MARCH 28, 2025
Many everyday skills, such as speech, are not innate. They are learned through trial and error. Now, by analyzing young songbirds rehearsing their fathers' songs, researchers at Columbia's Zuckerman Institute have for the first time witnessed the role that the brain's reward machinery plays as the brain naturally learns over time through practice.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
MARCH 28, 2025
The Weill Cancer Hub East has been established to explore the interplay between nutrition and immunotherapy in cancer treatment.
Medical Xpress
MARCH 28, 2025
As a measles outbreak spreads across the U.S., doctors are now seeing a new and unexpected danger: children getting sick from taking too much vitamin A.
Pharmaceutical Technology
MARCH 28, 2025
Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.
Medical Xpress
MARCH 28, 2025
Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of mutations. Although some of these alterations should be recognized as a threat by our defenses, melanomas often escape immune system surveillance. As a result, more than half of patients do not generally respond to current immunotherapies.
pharmaphorum
MARCH 28, 2025
Eli Lilly's DTC platform LillyDirect has been expanded to include in-person and telehealth services for people in the US living with Alzheimer's
Medical Xpress
MARCH 28, 2025
An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for babies found it to be almost 90% effective in reducing hospitalization rates and helped more than 500 WA families avoid a hospital stay.
pharmaphorum
MARCH 28, 2025
Fast-growing pharma group Chiesi has revealed plans to spend 430m on a new therapeutics manufacturing facility at its site in Milan
Medical Xpress
MARCH 28, 2025
A team of Norwegian researchers, through international collaboration, found that the use of artificial intelligence (AI) during colonoscopy increased the detection of polyps by about 8%, but the risk of cancer was minimally affected.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
MARCH 28, 2025
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial
Medical Xpress
MARCH 28, 2025
In a position statement issued by the American Academy of Neurology and published online March 12 in Neurology, an updated consensus is presented relating to seizures, driving licensure, and medical reporting.
Pharmaceutical Commerce
MARCH 28, 2025
The latest news for pharma industry insiders.
Medical Xpress
MARCH 28, 2025
Damaged human livers can repair themselves. Even livers badly scarred from excessive alcohol use, including alcohol-related hepatitis and cirrhosis, have the potential to improve with a treatment plan that includes medication, abstinence, and emotional support.
Pharmaceutical Commerce
MARCH 28, 2025
Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support are working to evolve patient engagement strategies.
Medical Xpress
MARCH 28, 2025
Exercise could potentially reduce the recurrence rate of breast cancer, new research from Edith Cowan University (ECU) has found.
XTalks
MARCH 28, 2025
The pharmaceutical industry is rapidly evolving as recent regulatory changes reshape operational strategies and market dynamics. Companies are now reassessing their preparedness to meet heightened compliance requirements while remaining agile and competitive. In this poll, share your insights on how well your organization is positioned to adapt to these transformative regulatory shifts.
Medical Xpress
MARCH 28, 2025
For anybody who's struggled to pull together a grocery list or plan a week of family meals, the promise of assistance from artificial intelligence is downright appetizing.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
MARCH 28, 2025
Discover the future of drug discovery with insights from Dr Michael Bauer in this exclusive video interview. Learn about Quantro Therapeutics and their groundbreaking research.
Medical Xpress
MARCH 28, 2025
For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is associated with increased rates of adverse composite and specific individual outcomes, according to a study published in the March/April issue of the Annals of Family Medicine.
pharmaphorum
MARCH 28, 2025
Structure-Based Drug Design Summit Returns This June Sara.
Medical Xpress
MARCH 28, 2025
Even preschool children can recognize a hypocrite. And, just like adults, they don't have the best opinion of such people: they assess hypocrites more negatively than they do other people who break commonly accepted rules, a study conducted by researchers from SWPS University shows.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
277 
Let's personalize your content